Together, these findings suggest that irisin may serve as an associative biomarker for identifying individuals at risk of obesity-related metabolic disturbances, whereas CCL2 and IL-1β may be more indicative of chronic adipose tissue inflammation. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.